← All companies

GPCR

Structure Therapeutics Inc.

GPCR Nasdaq Pharmaceutical Preparations EDGAR ↗

$48.36

-1.11 -2.24%

Key statistics

from XBRL data in SEC filings

Market cap

$10.3B

Revenue (TTM)

—

Net income (TTM)

-$170M

EPS (TTM)

$-0.88

P/E ratio

—

Dividend yield

—

Free cash flow

-$226M

Cash

$316M

Total assets

$1.51B

Gross margin

—

52-week range

$15.80 – $94.90

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Entered a material agreement; Results of operations (earnings release); Other events May 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 15, 2026 8-K Regulation FD disclosure; Other events Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Entered a material agreement Jan 5, 2026 8-K Other events Dec 10, 2025 8-K Regulation FD disclosure; Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 25, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Sep 17, 2024 8-K Director or officer change Aug 27, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results; Other events Jun 27, 2024 8-K Other events Jun 3, 2024 8-K Regulation FD disclosure; Other events Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 8, 2024 8-K Results of operations (earnings release) Mar 8, 2024 8-K Regulation FD disclosure; Other events Dec 18, 2023 10-Q Quarter ended 2023-09-30 Nov 17, 2023 10-Q/A Quarter ended 2023-06-30 Nov 17, 2023 10-Q/A Quarter ended 2023-06-30 Nov 16, 2023 8-K Entered a material agreement; Results of operations (earnings release) Nov 14, 2023 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 29, 2023 8-K Regulation FD disclosure Sep 29, 2023